Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Not applicableStudy completedNCT01767389
What this trial is testing

Glucagon-like Peptide (GLP) Utilization and Safety

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1
Not applicableLooking for participantsNCT07740291
What this trial is testing

Tirzepatide Impact Assessment Study

Who this might be right for
Obesity & OverweightCardiometabolic Health IndicatorsAddiction+2 more
Texas Tech University 27
Not applicableNot Yet RecruitingNCT06775093
What this trial is testing

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

Who this might be right for
Polycystic Ovary SyndromeObesityInfertility, Female
Peking University Third Hospital 392
Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Post-approval studies (Phase 4)Study completedNCT03151005
What this trial is testing

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Who this might be right for
Polycystic Ovary Syndrome (PCOS)OverweightObesity
Xinqiao Hospital of Chongqing 70
Early research (Phase 1)Study completedNCT03341013
What this trial is testing

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 24
Not applicableUnknownNCT06388213
What this trial is testing

Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

Who this might be right for
Diabetes Mellitus, Type 2AnesthesiaPulmonary Aspiration of Gastric Contents
University Hospital, Geneva 40
Not applicableNot Yet RecruitingNCT06546384
What this trial is testing

GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease

Who this might be right for
AdiposityFatty LiverAlcohol Use Disorder
Insel Gruppe AG, University Hospital Bern 64
Testing effectiveness (Phase 2)Study completedNCT02082496
What this trial is testing

GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

Who this might be right for
Obesity
University of Copenhagen 50
Not applicableLooking for participantsNCT07495904
What this trial is testing

Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance

Who this might be right for
Obesity
Hellenic Mediterranean University 130
Not applicableStudy completedNCT04295005
What this trial is testing

A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 24,500
Not applicableNot Yet RecruitingNCT07340112
What this trial is testing

Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia

Who this might be right for
Peripheral Arterial Disease (PAD)Claudication, IntermittentChronic Limb-Threatening Ischemia
University Hospital, Strasbourg, France 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Early research (Phase 1)Looking for participantsNCT06576401
What this trial is testing

Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects

Who this might be right for
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 10
Not applicableNot Yet RecruitingNCT07687667
What this trial is testing

Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS

Who this might be right for
Polycystic Ovary Syndrome (PCOS)ObesityInfertility, Female
Peking University Third Hospital 406
Early research (Phase 1)Looking for participantsNCT05071898
What this trial is testing

Pharmacogenetics of Response to GLP1R Agonists

Who this might be right for
ObesityDiabetes Type 2
University of Maryland, Baltimore 600
Not applicableUnknownNCT03959865
What this trial is testing

GLP-1 REceptor Agonists and Real World EvIdeNce

Who this might be right for
Type 2 Diabetes
University of Padova 6,000
Testing effectiveness (Phase 2)Study completedNCT03712098
What this trial is testing

Daily Liraglutide for Nicotine Dependence

Who this might be right for
Smoking CessationWeight, Body
Rebecca Ashare 40
Next Page